促红细胞生成素
贫血
医学
癌症
重组DNA
内科学
肿瘤科
重症监护医学
基因
生物
生物化学
标识
DOI:10.1016/s0889-8588(18)30141-2
摘要
Anemia is common in cancer patients and may require treatment for symptomatic palliation. Transfusion has been the mainstay of therapy, but is not without risk. Because erythropoietin levels in cancer-related anemia are inadequate for the degree of anemia, recombinant human erythropoietin has been studied to treat the anemia. Results from these studies are encouraging.
科研通智能强力驱动
Strongly Powered by AbleSci AI